Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.

NCT06136377 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Patients With Metastatic Castration-resistant Prostate Cancer

Interventions

RADIATION: 177Lu-PSMA-617 PET scan

Sponsor

Centre Georges Francois Leclerc